The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: Results of an in vitro study

A. Tripodi, V. Chantarangkul, C. Guinet, M. M. Samama

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)226-228
Number of pages3
JournalJournal of Thrombosis and Haemostasis
Volume9
Issue number1
DOIs
Publication statusPublished - Jan 2011

ASJC Scopus subject areas

  • Hematology

Cite this